0002008210-24-000001.txt : 20240131 0002008210-24-000001.hdr.sgml : 20240131 20240131112133 ACCESSION NUMBER: 0002008210-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(5) FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 EFFECTIVENESS DATE: 20240131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexPoint Life Sciences III DST CENTRAL INDEX KEY: 0002008210 ORGANIZATION NAME: IRS NUMBER: 883907129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-503969 FILM NUMBER: 24581275 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (833) 697-6246 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 D 1 primary_doc.xml X0708 D LIVE 0002008210 NexPoint Life Sciences III DST 300 CRESCENT COURT SUITE 700 DALLAS TX TEXAS 75201 (833) 697-6246 DELAWARE None None Other Delaware Statutory Trust true 2023 N/A NexPoint Real Estate Advisors IV, L.P. 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Sponsor of the Issuer Brian Mitts 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer Matt McGraner 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer N/A NREA LS III Manager, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Manager and Signatory Trustee of the Issuer N/A NREA LS III Contributor, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Contributor of the Issuer Other Real Estate Decline to Disclose 06c 3C 3C.1 3C.5 false 2024-01-25 false true true false 100000 Aurora Securities 46147 None None 2565 West Maple Troy MI MICHIGAN 48084 WA WASHINGTON false 30661253 148529 30512724 Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion. false 1 2682859 true 0 true Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid. 761468 true Item 16 is an estimate of offering expenses and acquisition fees that may accrue to one or more Related Persons. false NexPoint Life Sciences III DST /s/Brian Mitts Brian Mitts Authorized Signatory of the Issuer 2024-01-31